Could liquid biopsies help deliver better treatment?
Author:
- Michael EisensteinMEMichael Eisenstein
- 25 March 2020
- journal article
- editorial
- Published by Springer Nature in Nature
- Vol. 579 (7800) , S6-S8
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Circulating Tumor DNA Analysis for Detection of Minimal Residual Disease After Chemoradiotherapy for Localized Esophageal CancerGastroenterology, 2020
- Simultaneous multi-cancer detection and tissue of origin (TOO) localization using targeted bisulfite sequencing of plasma cell-free DNA (cfDNA)Annals of Oncology, 2019
- Liquid versus tissue biopsy for detecting acquired resistance and tumor heterogeneity in gastrointestinal cancersNature Medicine, 2019
- Detection and localization of surgically resectable cancers with a multi-analyte blood testScience, 2018
- An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverageNature Medicine, 2014
- Clinical validity of circulating tumour cells in patients with metastatic breast cancer: a pooled analysis of individual patient dataThe Lancet Oncology, 2014
- Abstract 2410: Circulating tumor cells to guide the choice between chemotherapy and hormone therapy as first line treatment for metastatic breast cancer patients: the STIC CTC METABREAST trial.Cancer Research, 2013